Literature DB >> 27246642

[The prevalence of Candida pelliculosa, Candida utilis, and Candida fabianii in the Olomouc University Hospital: epidemiological study].

L Svobodová, D Bednářová, P Hamal.   

Abstract

BACKGROUND: The aims of this study were to determine the prevalence of C. pelliculosa, C. utilis, and C. fabianii in clinical samples collected from patients hospitalized in the Olomouc University Hospital and compare their minimum inhibitory concentrations (MICs ) to nine systemic antifungals with respect to yeast species, patient age, gender, and site of infection.
MATERIAL AND METHODS: Identification was performed biochemically and using mass spectrometry (MALDI-TOF MS). MICs were determined by the broth dilution method.
RESULTS: Of a total of 163 clinical isolates, 119 were biochemically identified as C. pelliculosa and 44 as C. utilis. Using MALDI-TOF MS, 152 isolates were identified as C. fabianii, six as C. pelliculosa, three as C. utilis, and one as Ogataea polymorpha. The highest mean MICs were found in C. fabianii and in yeasts isolated from blood cultures and central venous catheters.
CONCLUSIONS: The MALDI-TOF MS found C. fabianii to be most prevalent in clinical samples as compared with the other studied species. The probable cause of discordant results between the two methods was the absence of C. fabianii in the database of the biochemical test kit which led to misidentification of this species. Higher MIC values in C. fabianii demonstrate the importance of the precise identification of this species.

Entities:  

Keywords:  Candida fabianii - epidemiology - identification - MALDI-TOF - antifungals.

Mesh:

Substances:

Year:  2016        PMID: 27246642

Source DB:  PubMed          Journal:  Epidemiol Mikrobiol Imunol        ISSN: 1210-7913            Impact factor:   0.444


  1 in total

Review 1.  Unequivocal identification of an underestimated opportunistic yeast species, Cyberlindnera fabianii, and its close relatives using a dual-function PCR and literature review of published cases.

Authors:  Amir Arastehfar; Wenjie Fang; Abdullah M S Al-Hatmi; Mohammad Hosein Afsarian; Farnaz Daneshnia; Mina Bakhtiari; Sara Khanjari Sadati; Hamid Badali; Sadegh Khodavaisy; Ferry Hagen; Wanqing Liao; Weihua Pan; Kamiar Zomorodian; Teun Boekhout
Journal:  Med Mycol       Date:  2019-10-01       Impact factor: 4.076

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.